Chatham Capital Group’s ResMed RMD Stock Holding History

Chatham Capital Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,100	Closed	-$247K	–	205
2026 Q1	$247K	Hold	1,100	–	–	0.04%	191
2025 Q4	$265K	Hold	1,100	–	–	0.04%	190
2025 Q3	$301K	Hold	1,100	–	–	0.04%	184
2025 Q2	$284K	Sell	1,100 -150	-12%	-$35.8K	0.04%	185
2025 Q1	$280K	Hold	1,250	–	–	0.05%	182
2024 Q4	$286K	Hold	1,250	–	–	0.05%	180
2024 Q3	$305K	Hold	1,250	–	–	0.05%	173
2024 Q2	$239K	Hold	1,250	–	–	0.04%	180
2024 Q1	$248K	Hold	1,250	–	–	0.05%	179
2023 Q4	$215K	Buy	+1,250	New	+$192K	0.04%	178
2023 Q3	–	Sell	-1,250	Closed	-$273K	–	190
2023 Q2	$273K	Hold	1,250	–	–	0.06%	172
2023 Q1	$274K	Hold	1,250	–	–	0.06%	170
2022 Q4	$260K	Hold	1,250	–	–	0.06%	171
2022 Q3	$273K	Hold	1,250	–	–	0.07%	161
2022 Q2	$262K	Hold	1,250	–	–	0.06%	168
2022 Q1	$303K	Sell	1,250 -740	-37%	-$179K	0.06%	160
2021 Q4	$518K	Hold	1,990	–	–	0.09%	145
2021 Q3	$524K	Hold	1,990	–	–	0.1%	142
2021 Q2	$491K	Hold	1,990	–	–	0.09%	141
2021 Q1	$386K	Hold	1,990	–	–	0.08%	145
2020 Q4	$423K	Hold	1,990	–	–	0.1%	135
2020 Q3	$341K	Hold	1,990	–	–	0.08%	131
2020 Q2	$382K	Sell	1,990 -350	-15%	-$57.3K	0.1%	126
2020 Q1	$345K	Hold	2,340	–	–	0.1%	131
2019 Q4	$363K	Hold	2,340	–	–	0.09%	137
2019 Q3	$316K	Hold	2,340	–	–	0.08%	137
2019 Q2	$286K	Hold	2,340	–	–	0.07%	145
2019 Q1	$243K	Hold	2,340	–	–	0.06%	147
2018 Q4	$266K	Hold	2,340	–	–	0.07%	141
2018 Q3	$270K	Hold	2,340	–	–	0.07%	133
2018 Q2	$242K	Hold	2,340	–	–	0.06%	139
2018 Q1	$230K	Buy	+2,340	New	+$221K	0.06%	137
2017 Q2	–	Sell	-21,405	Closed	-$1.54M	–	155
2017 Q1	$1.54M	Sell	21,405 -2,040	-9%	-$141K	0.43%	48
2016 Q4	$1.46M	Buy	23,445 +4,400	+23%	+$269K	0.42%	55
2016 Q3	$1.23M	Sell	19,045 -750	-4%	-$49.9K	0.39%	50
2016 Q2	$1.25M	Hold	19,795	–	–	0.39%	49
2016 Q1	$1.15M	Sell	19,795 -400	-2%	-$22.6K	0.36%	54
2015 Q4	$1.08M	Hold	20,195	–	–	0.35%	60
2015 Q3	$1.03M	Sell	20,195 -250	-1%	-$13.5K	0.35%	59
2015 Q2	$1.15M	Hold	20,445	–	–	0.32%	63
2015 Q1	$1.47M	Buy	20,445 +550	+3%	+$35.7K	0.43%	50
2014 Q4	$1.11M	Hold	19,895	–	–	0.33%	60
2014 Q3	$980K	Buy	19,895 +200	+1%	+$10.2K	0.3%	68
2014 Q2	$997K	Hold	19,695	–	–	0.39%	57
2014 Q1	$880K	Hold	19,695	–	–	0.36%	58
2013 Q4	$927K	Hold	19,695	–	–	0.39%	59
2013 Q3	$1.04M	Hold	19,695	–	–	0.47%	47
2013 Q2	$889K	Buy	+19,695	New	+$934K	0.43%	49

Other funds holding RMD

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

LTAS

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

Chatham Capital Group's RMD Position: Q2 2026 in Review

Chatham Capital Group sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,100 shares — an estimated $247K sold.

Chatham Capital Group first reported a position in RMD in Q2 2013 and held it in 48 quarters. The position peaked at $1.54M in Q1 2017. 103 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Chatham Capital Group reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
Chatham Capital Group sold 1,100 ResMed shares in Q2 2026, an estimated $247K.
Chatham Capital Group first reported a position in ResMed in Q2 2013 and held it in 48 quarters.
Chatham Capital Group's ResMed position peaked at $1.54M in Q1 2017.
103 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Chatham Capital Group's 13F filing for Q2 2026, filed 13 Jul 2026.